IP Library Granted Patent US 9,803,175
Granted Patent B2
US 9,803,175 · App. 14/380,165 · Granted Oct 31, 2017

Generation of neural stem cells and motor neurons

Inventors: Chaya Brodie (Southfield, MI); Shimon Slavin (Tel-Aviv, IL)
Assignees: EXOSTEM BIOTEC LTD.; HENRY FORD HEALTH SYSTEM
C12N5/0623A61K35/28C12N5/0619C12Q1/6876C12N15/113C12N2310/141C12N2320/11C12N2330/10C12N2501/11C12N2501/115C12N2501/13C12N2501/385C12N2501/41C12N2501/65C12N2501/91C12N2501/998C12N2501/999C12N2506/025C12N2506/08C12N2506/1353C12N2506/1369C12N2506/1384C12N2506/1392C12N2510/00C12Q2600/158C12Q2600/178
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,803,175
App. No.
14/380,165
Granted
Oct 31, 2017
Kind
B2
Abstract

A method of generating neural stem cells or motor neurons is disclosed, the method comprising up-regulating a level of at least one exogenous miRNA and/or down-regulating at least one miRNA using an agent which hybridizes to the miRNA in mesenchymal stem cells (MSCs) or down-regulating Related to testis-specific, vespid and pathogenesis protein 1 (RTVP-1).

Claims (16)

1. A method of promoting mesenchymal stem cell (MSC) differentiation toward a neuronal stem cell, the method comprising:

(i) culturing a MSC in a medium supporting neuronal stem cell growth and differentiation,

(ii) introducing into said MSC at least one exogenous microRNA (miR) selected from the group consisting of miR-20B, miR-378 and miR-891,

(iii) introducing into said MSC a miR-138 antagomir, and

(iv) confirming increased expression at least one neuronal marker selected from the group consisting of nesting and Sox2 by detecting expression of said marker on said MSC, thereby promoting differentiation of the MSC into the neuronal stem cell.

2. The method of claim 1 , wherein said introducing comprises any one of:

(i) transfecting said MSCs with an expression vector which comprises a polynucleotide sequence which encodes a pre-miRNA of said miR; or

(ii) transfecting said MSCs with an expression vector which comprises a polynucleotide sequence which encodes said miR.

3. A method of promoting mesenchymal stem cell (MSC) differentiation toward a neuronal stem cell, the method comprising:

(i) culturing a MSC in a medium supporting neuronal stem cell growth and differentiation,

(ii) introducing into said MSC at least one exogenous microRNA (miR) selected from the group consisting of miR-20B, miR-378 and miR-891,

(iii) introducing into said MSC a miR-138 antagomir,

(iv) confirming expression at least one neuronal marker selected from the group consisting of nesting and Sox2, wherein said expressing results in at least 50% of the MSCs expressing said neuronal marker, thereby promoting differentiation of the MSC into the neuronal stem cell.

4. The method of claim 3 , wherein said introducing comprises any one of:

(i) transfecting said MSCs with an expression vector which comprises a polynucleotide sequence which encodes a pre-miRNA of said miR; or

(ii) transfecting said MSCs with an expression vector which comprises a polynucleotide sequence which encodes said miR.

Assignments (3)
CHANGE OF NAME Recorded Aug 23, 2017
From: BRAINSTEM BIOTEC LTD.
To: EXOSTEM BIOTEC LTD.
Reel/Frame 043373/0534 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 15, 2015
From: BRODIE, CHAYA
To: HENRY FORD HEALTH SYSTEM
Reel/Frame 034965/0019 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 15, 2015
From: SLAVIN, SHIMON
To: BRAINSTEM BIOTEC LTD.
Reel/Frame 034965/0021 →
Continuity (2)
Provisional Application 61601596 · Feb 22, 2012
Related Publication 20150037299A1 · Feb 5, 2015